Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-025537
Filing Date
2024-10-22
Accepted
2024-10-22 20:18:32
Documents
1
Period of Report
2024-10-21

Document Format Files

Seq Description Document Type Size
1 form4-10232024_121029.html 4  
1 form4-10232024_121029.xml 4 4003
  Complete submission text file 0001415889-24-025537.txt   5457
Mailing Address C/O ALLOGENE THERAPEUTICS, INC. 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
MOORE ALISON (Reporting) CIK: 0001754937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42179 | Film No.: 241387595

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)